Mycophenolate Mofetil

Drug Akorn, Inc.
Total Payments
$10,191
Transactions
39
Doctors
6
Companies
6

Payment Trends by Year

Year Amount Transactions Doctors
2024 $77.58 3 3
2023 $30.77 1 1
2020 $3,083 4 3
2019 $5,833 11 3
2018 $879.23 16 4
2017 $287.85 4 3

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $5,808 10 57.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,825 21 37.5%
Unspecified $558.19 8 5.5%

Payments by Type

General
$9,633
31 transactions
Research
$558.19
8 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Mycophenolate REMS Teva Pharmaceuticals USA, Inc. $558.19 4

Top Doctors Receiving Payments for Mycophenolate Mofetil

Doctor Specialty Location Total Records
Michelle Josephson Nephrology Chicago, IL $3,240 5
, MD Pediatrics Little Rock, AR $3,174 19
Adolfo Correa Jackson, MS $2,641 5
, MD Nephrology Providence, RI $995.84 7
, D.M.D Pediatric Dentistry Jackson, MS $62.50 1
, MD Maternal & Fetal Medicine Galveston, TX $57.40 1
, MD Pediatric Rheumatology Chicago, IL $21.55 1

About Mycophenolate Mofetil

Mycophenolate Mofetil is a drug associated with $10,191 in payments to 6 healthcare providers, recorded across 39 transactions in the CMS Open Payments database. The primary manufacturer is Akorn, Inc..

Payment data is available from 2017 to 2024. In 2024, $77.58 was paid across 3 transactions to 3 doctors.

The most common payment nature for Mycophenolate Mofetil is "Consulting Fee" ($5,808, 57.0% of total).

Mycophenolate Mofetil is associated with 1 research study, including "Mycophenolate REMS" ($558.19).